Assuntos
Doenças do Colo/etiologia , Duodenopatias/etiologia , Fístula Gástrica/etiologia , Fístula Intestinal/etiologia , Fístula Pancreática/etiologia , Pancreatite/complicações , Adulto , Doenças do Colo/diagnóstico , Duodenopatias/diagnóstico , Fístula Gástrica/diagnóstico , Humanos , Fístula Intestinal/diagnóstico , Masculino , Pessoa de Meia-Idade , Fístula Pancreática/diagnóstico , Estudos Retrospectivos , Fatores de TempoRESUMO
BACKGROUND AND AIM: There is scanty data on the occurrence of celiac disease in patients with type 1 diabetes mellitus in South Asia. Our aim was to study the prevalence and clinical profile of celiac disease in patients with type 1 diabetes mellitus in a tertiary care referral centre in north India. METHODS: Consecutive patients of type 1 diabetes mellitus attending the Endocrine clinic of our institute between January 2002 and December 2008 were screened using anti-tissue transglutaminase antibodies (tTGAb), and those positive were subjected to duodenal biopsy. Clinical profile of these patients was recorded. RESULTS: Out of 189 patients of type 1 diabetes mellitus, 21 (11.1%) were diagnosed to have celiac disease on the basis of positive serology (tTGAb) and duodenal histology. The mean age at diagnosis of diabetes was 10.81 ± 7.3 years and that of celiac disease was 13.74 ± 5.71 years, with a difference of 5.18 ± 4.75 years between the two. Only 2/21 patients with celiac disease had been diagnosed before detection of diabetes mellitus. Short stature was the commonest (52.3%) manifestation of celiac disease, followed by anemia (47.3), weight loss (42.8%), diarrhea (28.6%) and abdominal pain (14.2%). After initiating gluten free diet, 14/16 symptomatic patients had reversal of anemia, weight loss and diarrhea. Growth rate velocity improved from 2.3 ± 1.0 cm/year to 5.5 ± 2.4 cm/year in those with short stature. CONCLUSION: Celiac disease is highly prevalent in patients with type 1 diabetes mellitus (11.1%) and majority of them (90.5%) were diagnosed on screening. Routine screening is required for early diagnosis and combat associated co-morbidities.
Assuntos
Doença Celíaca/epidemiologia , Diabetes Mellitus Tipo 1/epidemiologia , Dor Abdominal/epidemiologia , Adolescente , Adulto , Anemia/epidemiologia , Autoanticorpos/sangue , Biópsia , Doença Celíaca/dietoterapia , Doença Celíaca/imunologia , Doença Celíaca/patologia , Criança , Pré-Escolar , Diarreia/epidemiologia , Dieta Livre de Glúten , Duodenoscopia , Duodeno/patologia , Diagnóstico Precoce , Feminino , Proteínas de Ligação ao GTP , Transtornos do Crescimento/epidemiologia , Humanos , Índia/epidemiologia , Masculino , Valor Preditivo dos Testes , Prevalência , Proteína 2 Glutamina gama-Glutamiltransferase , Estudos Retrospectivos , Fatores de Tempo , Transglutaminases/imunologia , Resultado do Tratamento , Redução de Peso , Adulto JovemRESUMO
CONTEXT: Non-operative strategies are gaining preference in the management of patients with severe acute pancreatitis. OBJECTIVE: The present study was undertaken to evaluate the efficacy of a non-operative approach, including percutaneous drainage, in the management of severe acute pancreatitis. DESIGN: Prospective study. SETTING: Tertiary care centre in India. PATIENTS: Fifty consecutive patients with severe acute pancreatitis were managed in an intensive care unit. INTERVENTIONS: The patients were initially managed conservatively. Those with 5 cm, or more, of fluid collection having fever, leukocytosis or organ failure underwent percutaneous catheter drainage using a 10 Fr catheter. Those not responding underwent a necrosectomy. Depending on the outcome of their supportive care, the patients were divided into three groups: those responding to intensive care, those needing percutaneous catheter drainage and those requiring surgical intervention. Twelve patients were managed conservatively (Group 1) while 24 underwent percutaneous catheter drainage (Group 2), 9 of whom were not operated (Group 2a) and 15 of whom underwent necrosectomy (Group 2b). Fourteen patients were operated on directly (Group 3). MAIN OUTCOME MEASURES: Hospital stay, intensive care unit stay, and mortality. RESULTS: Among patients requiring surgery, the patients in Group 2b had a shorter intensive care unit stay (22.1±11.1 days) as compared to the patients in Group 3 (25.0±15.6 days) and a longer interval to surgery, 30.7±8.9 days versus 25.4±8.5 days. However, these differences did not reach statistical significance (P=0.705 and P=0.133, respectively). The two groups did not differ in terms of mortality (5/15 versus 3/14; P=0.682). CONCLUSION: The use of percutaneous catheter drainage helped avoid or delay surgery in two-fifths of the patients with severe acute pancreatitis.